The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation.
<h4>Objective</h4>To explore external validity of randomized controlled trials (RCTs) of hypertension within China from the view of sample representation.<h4>Methods</h4>Comprehensive literature searches were performed in Medline, Embase, Cochrane Central Register of Controll...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6d176f9497254fa1a26289445d101ead |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6d176f9497254fa1a26289445d101ead |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6d176f9497254fa1a26289445d101ead2021-11-18T08:43:07ZThe external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation.1932-620310.1371/journal.pone.0082324https://doaj.org/article/6d176f9497254fa1a26289445d101ead2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24324771/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>To explore external validity of randomized controlled trials (RCTs) of hypertension within China from the view of sample representation.<h4>Methods</h4>Comprehensive literature searches were performed in Medline, Embase, Cochrane Central Register of Controlled Trials (CCTR) et al and advanced search strategies were used to locate hypertension RCTs as well as observational studies conducted in China during 1996 to 2009 synchronously. The risk of bias in RCTs and observational studies was assessed by two modified scales respectively, and then both types of studies with 3 or more grading scores were included for the purpose of evaluating of external validity. Following that the study characteristics relative to sample representation were extracted from RCTs and observational studies synchronously, and the later were taken as external references for validating sample representation of RCTs.<h4>Results</h4>226 hypertension RCTs and 21 observational studies were included for final analysis. Comparing samples with observational studies, the mean age of samples within RCTs was 54.46 years, significantly lower than that of observational studies (66.35 years) (P=0.002). The average disease course in patients of RCTs was 3.89 years and grade III hypertensive patients accounted for 17%; both were lower than that of the observational studies (12.96 years, P<0.001; 34%, P=0.026 respectively). In addition, the proportions of patients with complications due to heart failure, stroke, diabetes, or coronary heart disease in RCTs were 8%, 5%, 12% and 11% correspondingly, all of which were significantly less than that of observational studies (11%, 18%, 17% and 29%).<h4>Conclusion</h4>Sample characteristics within hypertension RCTs were significantly different from those in observational studies. The samples in most RCTs were under-represented. It's feasible to take samples of observational studies as a mirror of the actual composition of hypertension patients in the real world, if the reporting of observational studies is abundant and available.Xin ZhangYuxia WuDeying KangJialiang WangQi HongLe PengPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e82324 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Xin Zhang Yuxia Wu Deying Kang Jialiang Wang Qi Hong Le Peng The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| description |
<h4>Objective</h4>To explore external validity of randomized controlled trials (RCTs) of hypertension within China from the view of sample representation.<h4>Methods</h4>Comprehensive literature searches were performed in Medline, Embase, Cochrane Central Register of Controlled Trials (CCTR) et al and advanced search strategies were used to locate hypertension RCTs as well as observational studies conducted in China during 1996 to 2009 synchronously. The risk of bias in RCTs and observational studies was assessed by two modified scales respectively, and then both types of studies with 3 or more grading scores were included for the purpose of evaluating of external validity. Following that the study characteristics relative to sample representation were extracted from RCTs and observational studies synchronously, and the later were taken as external references for validating sample representation of RCTs.<h4>Results</h4>226 hypertension RCTs and 21 observational studies were included for final analysis. Comparing samples with observational studies, the mean age of samples within RCTs was 54.46 years, significantly lower than that of observational studies (66.35 years) (P=0.002). The average disease course in patients of RCTs was 3.89 years and grade III hypertensive patients accounted for 17%; both were lower than that of the observational studies (12.96 years, P<0.001; 34%, P=0.026 respectively). In addition, the proportions of patients with complications due to heart failure, stroke, diabetes, or coronary heart disease in RCTs were 8%, 5%, 12% and 11% correspondingly, all of which were significantly less than that of observational studies (11%, 18%, 17% and 29%).<h4>Conclusion</h4>Sample characteristics within hypertension RCTs were significantly different from those in observational studies. The samples in most RCTs were under-represented. It's feasible to take samples of observational studies as a mirror of the actual composition of hypertension patients in the real world, if the reporting of observational studies is abundant and available. |
| format |
article |
| author |
Xin Zhang Yuxia Wu Deying Kang Jialiang Wang Qi Hong Le Peng |
| author_facet |
Xin Zhang Yuxia Wu Deying Kang Jialiang Wang Qi Hong Le Peng |
| author_sort |
Xin Zhang |
| title |
The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| title_short |
The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| title_full |
The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| title_fullStr |
The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| title_full_unstemmed |
The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation. |
| title_sort |
external validity of randomized controlled trials of hypertension within china: from the perspective of sample representation. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/6d176f9497254fa1a26289445d101ead |
| work_keys_str_mv |
AT xinzhang theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT yuxiawu theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT deyingkang theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT jialiangwang theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT qihong theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT lepeng theexternalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT xinzhang externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT yuxiawu externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT deyingkang externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT jialiangwang externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT qihong externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation AT lepeng externalvalidityofrandomizedcontrolledtrialsofhypertensionwithinchinafromtheperspectiveofsamplerepresentation |
| _version_ |
1718421388726894592 |